Dov A. Goldstein MD - 23 Apr 2026 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Reporting relationship: Chief Financial Officer
Issuer ticker: BIOA
Reported as of: 23 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Apr 2026, 16:19:14 UTC
Prior SEC filing: 03 Mar 2026
Next SEC filing: 17 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Dov A. Goldstein

Key filing fact

Dov A. Goldstein MD filed Form 4 for BioAge Labs, Inc. (BIOA) on 24 Apr 2026.

Key facts

This page summarizes Dov A. Goldstein MD's Form 4 filing for BioAge Labs, Inc. (BIOA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Apr 2026, 16:19.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001120478 Primary reporting owner

GOLDSTEIN DOV A MD

Relationship: Chief Financial Officer
Address: C/O BIOAGE LABS, INC., 5885 HOLLIS STREET, SUITE 370, EMERYVILLE
Signature: /s/ Dov A. Goldstein
Signature date: 24 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIOA transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,542
Change %: +11%
Price: $4.38^*
Shares after: 36,575
Date: 23 Apr 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIOA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -3,542
Change %: -2.2%
Price: $0.000000^*
Shares after: 155,833
Date: 23 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,542
Exercise price: $4.38
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.